21st.BIOs Novel Food application for the milk protein beta-lactoglobulin (BLG), marks a significant step toward producing high-quality proteins in Europe with fewer resources while helping address supply constraints in the European whey protein market. When approved by EFSA, 21st.BIO's BLG Essential+ can enable resource-efficient milk protein production and sale in Europe using industrially proven precision fermentation technology. This highlights the need for a predictable, fast-track EU approval process for well-characterized, nature-identical food proteins produced using technologies with a demonstrated safety record.
Read more at prnewswire.com
21st.BIO files EU Novel Food application for BLG Essential+™ and calls for a European home market for industrially proven precision fermentation technology for production of food
Barchart · 2d ago
Share
Listen to the news
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending